| 0 |
EYE FLAT BLEB |
2 |
1.0000 |
| 1 |
VASCULAR ACCESS SITE INJURY |
2 |
0.2500 |
| 2 |
CONJUNCTIVAL FILTERING BLEB LEAK |
2 |
0.0526 |
| 3 |
GLAUCOMATOUS OPTIC NEUROPATHY |
1 |
0.0500 |
| 4 |
CONJUNCTIVAL PAPILLAE |
1 |
0.0500 |
| 5 |
VASCULAR ACCESS SITE BRUISING |
2 |
0.0370 |
| 6 |
RETINOPATHY HAEMORRHAGIC |
2 |
0.0303 |
| 7 |
HAEMORRHAGIC OCCLUSIVE RETINAL VASCULITIS |
2 |
0.0274 |
| 8 |
CORNEAL TOXICITY |
3 |
0.0270 |
| 9 |
NERVE DEGENERATION |
4 |
0.0222 |
| 10 |
IDIOPATHIC ORBITAL INFLAMMATION |
4 |
0.0208 |
| 11 |
KERATITIS INTERSTITIAL |
1 |
0.0196 |
| 12 |
CATHETER SITE SCAR |
1 |
0.0167 |
| 13 |
CORNEAL LEUKOMA |
1 |
0.0167 |
| 14 |
PRODUCT STERILITY ISSUE |
2 |
0.0163 |
| 15 |
CHORIORETINAL FOLDS |
1 |
0.0141 |
| 16 |
HISTOLOGY ABNORMAL |
3 |
0.0136 |
| 17 |
CATARACT CORTICAL |
2 |
0.0134 |
| 18 |
EYE INFECTION INTRAOCULAR |
1 |
0.0128 |
| 19 |
KERATOMILEUSIS |
3 |
0.0117 |
| 20 |
CONJUNCTIVITIS VIRAL |
3 |
0.0113 |
| 21 |
OCULAR SURFACE DISEASE |
3 |
0.0107 |
| 22 |
ADMINISTRATION SITE WOUND |
1 |
0.0101 |
| 23 |
DIALYSIS HYPOTENSION |
1 |
0.0101 |
| 24 |
PERSISTENT CORNEAL EPITHELIAL DEFECT |
1 |
0.0085 |
| 25 |
IRIS NEOVASCULARISATION |
1 |
0.0080 |
| 26 |
CRUSH INJURY |
1 |
0.0078 |
| 27 |
CORNEAL EROSION |
4 |
0.0074 |
| 28 |
EYELID INFECTION |
3 |
0.0068 |
| 29 |
CORNEAL INFILTRATES |
2 |
0.0064 |
| 30 |
RETINAL DRUSEN |
1 |
0.0061 |
| 31 |
SEPTIC ENCEPHALOPATHY |
1 |
0.0058 |
| 32 |
ILLOGICAL THINKING |
1 |
0.0053 |
| 33 |
CONJUNCTIVAL DISORDER |
2 |
0.0052 |
| 34 |
OCULAR PROCEDURAL COMPLICATION |
1 |
0.0052 |
| 35 |
VESSEL PUNCTURE SITE BRUISE |
1 |
0.0050 |
| 36 |
IMPLANTATION COMPLICATION |
1 |
0.0048 |
| 37 |
OESOPHAGEAL ACHALASIA |
3 |
0.0047 |
| 38 |
HEART VALVE OPERATION |
2 |
0.0046 |
| 39 |
LASER THERAPY |
1 |
0.0044 |
| 40 |
MEIBOMIAN GLAND DYSFUNCTION |
2 |
0.0044 |
| 41 |
CORNEAL OPACITY |
6 |
0.0044 |
| 42 |
SCLERITIS |
7 |
0.0044 |
| 43 |
PRODUCT DESIGN ISSUE |
3 |
0.0042 |
| 44 |
MACULAR DETACHMENT |
1 |
0.0041 |
| 45 |
CORNEAL DEGENERATION |
1 |
0.0041 |
| 46 |
CORNEAL THINNING |
1 |
0.0039 |
| 47 |
DEVICE WIRELESS COMMUNICATION ISSUE |
1 |
0.0039 |
| 48 |
HYPHAEMA |
2 |
0.0038 |
| 49 |
PROCTITIS ULCERATIVE |
2 |
0.0033 |
| 50 |
OPEN ANGLE GLAUCOMA |
2 |
0.0033 |
| 51 |
CHALAZION |
2 |
0.0031 |
| 52 |
PRODUCT CLOSURE REMOVAL DIFFICULT |
3 |
0.0029 |
| 53 |
SINUSITIS BACTERIAL |
3 |
0.0028 |
| 54 |
INSTILLATION SITE PRURITUS |
1 |
0.0027 |
| 55 |
SURGICAL FAILURE |
3 |
0.0026 |
| 56 |
VASCULAR ACCESS COMPLICATION |
2 |
0.0025 |
| 57 |
MALIGNANT HYPERTENSION |
2 |
0.0023 |
| 58 |
MANTLE CELL LYMPHOMA RECURRENT |
1 |
0.0023 |
| 59 |
LENTICULAR OPACITIES |
1 |
0.0023 |
| 60 |
CORNEAL OEDEMA |
5 |
0.0022 |
| 61 |
CHORIORETINOPATHY |
3 |
0.0021 |
| 62 |
INFUSION SITE NODULE |
2 |
0.0021 |
| 63 |
ALLERGIC REACTION TO EXCIPIENT |
4 |
0.0020 |
| 64 |
SUSPECTED PRODUCT CONTAMINATION |
2 |
0.0020 |
| 65 |
EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS |
4 |
0.0020 |
| 66 |
RENAL MASS |
4 |
0.0019 |
| 67 |
INFUSION SITE CELLULITIS |
1 |
0.0019 |
| 68 |
INSTILLATION SITE ERYTHEMA |
1 |
0.0019 |
| 69 |
RENAL NEOPLASM |
4 |
0.0019 |
| 70 |
OPHTHALMIC HERPES SIMPLEX |
1 |
0.0017 |
| 71 |
OPTIC NERVE INJURY |
2 |
0.0017 |
| 72 |
CORNEAL EPITHELIUM DEFECT |
1 |
0.0017 |
| 73 |
DEVICE MAINTENANCE ISSUE |
1 |
0.0017 |
| 74 |
EYE BURNS |
1 |
0.0017 |
| 75 |
RETINAL VASCULITIS |
2 |
0.0017 |
| 76 |
ARTERIOVENOUS FISTULA SITE COMPLICATION |
1 |
0.0017 |
| 77 |
INFUSION SITE WARMTH |
2 |
0.0016 |
| 78 |
INCREASED VISCOSITY OF BRONCHIAL SECRETION |
1 |
0.0016 |
| 79 |
HEPATIC INFECTION |
2 |
0.0016 |
| 80 |
GINGIVAL DISCOMFORT |
1 |
0.0015 |
| 81 |
PRODUCT DELIVERY MECHANISM ISSUE |
8 |
0.0015 |
| 82 |
ABDOMINAL RIGIDITY |
4 |
0.0015 |
| 83 |
ULCERATIVE KERATITIS |
4 |
0.0015 |
| 84 |
OPHTHALMIC MIGRAINE |
1 |
0.0014 |
| 85 |
INTRAOCULAR PRESSURE TEST ABNORMAL |
1 |
0.0014 |
| 86 |
FACIAL DISCOMFORT |
1 |
0.0014 |
| 87 |
SYPHILIS |
1 |
0.0014 |
| 88 |
ANKLE OPERATION |
2 |
0.0014 |
| 89 |
CONJUNCTIVITIS ALLERGIC |
2 |
0.0013 |
| 90 |
CORNEAL DEPOSITS |
1 |
0.0013 |
| 91 |
PRODUCT KNOWLEDGE DEFICIT |
1 |
0.0013 |
| 92 |
IRIDOCYCLITIS |
4 |
0.0013 |
| 93 |
GROWTH OF EYELASHES |
1 |
0.0013 |
| 94 |
REACTION TO PRESERVATIVES |
1 |
0.0012 |
| 95 |
OCULAR VASCULAR DISORDER |
1 |
0.0012 |
| 96 |
INTRAOCULAR PRESSURE INCREASED |
15 |
0.0012 |
| 97 |
PRODUCT CONTAINER SEAL ISSUE |
2 |
0.0011 |
| 98 |
VASOCONSTRICTION |
1 |
0.0011 |
| 99 |
INFUSION SITE DISCHARGE |
2 |
0.0011 |
| 100 |
CONJUNCTIVAL HYPERAEMIA |
4 |
0.0011 |
| 101 |
LIGAMENT DISORDER |
1 |
0.0011 |
| 102 |
VENTRICULAR ARRHYTHMIA |
4 |
0.0011 |
| 103 |
PUNCTATE KERATITIS |
1 |
0.0011 |
| 104 |
CATHETER SITE SWELLING |
1 |
0.0011 |
| 105 |
SCROTAL SWELLING |
1 |
0.0011 |
| 106 |
PRODUCT AFTER TASTE |
1 |
0.0010 |
| 107 |
PRINZMETAL ANGINA |
1 |
0.0010 |
| 108 |
OCULAR DISCOMFORT |
11 |
0.0010 |
| 109 |
CONJUNCTIVAL OEDEMA |
1 |
0.0010 |
| 110 |
DEVICE MATERIAL ISSUE |
2 |
0.0010 |
| 111 |
AMAUROSIS FUGAX |
1 |
0.0009 |
| 112 |
SUPERFICIAL INJURY OF EYE |
1 |
0.0009 |
| 113 |
INFUSION SITE HAEMORRHAGE |
3 |
0.0009 |
| 114 |
PRODUCT LOT NUMBER ISSUE |
2 |
0.0009 |
| 115 |
EYELID DISORDER |
2 |
0.0009 |
| 116 |
INFUSION SITE INFECTION |
2 |
0.0009 |
| 117 |
INSTILLATION SITE IRRITATION |
1 |
0.0008 |
| 118 |
PENILE SWELLING |
1 |
0.0008 |
| 119 |
BLOOD PRESSURE SYSTOLIC ABNORMAL |
2 |
0.0008 |
| 120 |
TENDON INJURY |
3 |
0.0008 |
| 121 |
DEVICE INFUSION ISSUE |
2 |
0.0008 |
| 122 |
EYELID IRRITATION |
2 |
0.0008 |
| 123 |
BLOOD PRESSURE DIASTOLIC ABNORMAL |
2 |
0.0008 |
| 124 |
CARBON DIOXIDE INCREASED |
1 |
0.0007 |
| 125 |
EYE INFLAMMATION |
7 |
0.0007 |
| 126 |
CORNEAL ABRASION |
1 |
0.0007 |
| 127 |
IMMUNOGLOBULINS DECREASED |
1 |
0.0007 |
| 128 |
PERIORBITAL SWELLING |
4 |
0.0007 |
| 129 |
INVESTIGATION ABNORMAL |
1 |
0.0007 |
| 130 |
SEBORRHOEIC KERATOSIS |
1 |
0.0007 |
| 131 |
STRESS CARDIOMYOPATHY |
4 |
0.0007 |
| 132 |
BLOOD PRESSURE DIASTOLIC DECREASED |
5 |
0.0007 |
| 133 |
INFUSION SITE INDURATION |
1 |
0.0007 |
| 134 |
KERATITIS |
2 |
0.0007 |
| 135 |
EYE ALLERGY |
1 |
0.0006 |
| 136 |
RENAL CYST |
5 |
0.0006 |
| 137 |
FOREIGN BODY SENSATION IN EYES |
4 |
0.0006 |
| 138 |
AORTIC VALVE DISEASE |
1 |
0.0006 |
| 139 |
INJECTION RELATED REACTION |
1 |
0.0006 |
| 140 |
UVEITIS |
8 |
0.0006 |
| 141 |
RETINITIS |
1 |
0.0006 |
| 142 |
METASTASIS |
4 |
0.0006 |
| 143 |
PRODUCT TAMPERING |
1 |
0.0006 |
| 144 |
ERYTHEMA OF EYELID |
3 |
0.0006 |
| 145 |
DEVICE ALARM ISSUE |
1 |
0.0006 |
| 146 |
OCULAR HYPERAEMIA |
26 |
0.0005 |
| 147 |
SUSPECTED PRODUCT QUALITY ISSUE |
1 |
0.0005 |
| 148 |
VITRITIS |
1 |
0.0005 |
| 149 |
EYE PAIN |
30 |
0.0005 |
| 150 |
PHOTOPHOBIA |
10 |
0.0005 |
| 151 |
CYSTOID MACULAR OEDEMA |
1 |
0.0005 |
| 152 |
SACROILIITIS |
1 |
0.0005 |
| 153 |
GLAUCOMA |
10 |
0.0005 |
| 154 |
PATIENT DISSATISFACTION WITH TREATMENT |
1 |
0.0005 |
| 155 |
HYPERAEMIA |
1 |
0.0005 |
| 156 |
EYE IRRITATION |
29 |
0.0005 |
| 157 |
HYPOPHYSITIS |
1 |
0.0005 |
| 158 |
EYELID PAIN |
1 |
0.0005 |
| 159 |
SKIN INDURATION |
1 |
0.0005 |
| 160 |
ATRIAL TACHYCARDIA |
1 |
0.0005 |
| 161 |
OPTIC NEUROPATHY |
1 |
0.0005 |
| 162 |
TORTICOLLIS |
1 |
0.0005 |
| 163 |
CATHETER SITE ERYTHEMA |
1 |
0.0005 |
| 164 |
ABNORMAL SENSATION IN EYE |
2 |
0.0005 |
| 165 |
INFUSION SITE BRUISING |
1 |
0.0005 |
| 166 |
GASTROINTESTINAL HYPOMOTILITY |
1 |
0.0004 |
| 167 |
READING DISORDER |
1 |
0.0004 |
| 168 |
CONJUNCTIVITIS |
8 |
0.0004 |
| 169 |
LYMPHADENITIS |
1 |
0.0004 |
| 170 |
JUVENILE IDIOPATHIC ARTHRITIS |
1 |
0.0004 |
| 171 |
INSTILLATION SITE PAIN |
1 |
0.0004 |
| 172 |
OSTEITIS |
1 |
0.0004 |
| 173 |
INFUSION SITE PAIN |
5 |
0.0004 |
| 174 |
PRODUCT PACKAGING DIFFICULT TO OPEN |
1 |
0.0004 |
| 175 |
CLUMSINESS |
1 |
0.0004 |
| 176 |
ASTHENOPIA |
2 |
0.0004 |
| 177 |
RASH MORBILLIFORM |
1 |
0.0004 |
| 178 |
INFUSION SITE ERYTHEMA |
3 |
0.0004 |
| 179 |
NEUTROPHIL COUNT ABNORMAL |
1 |
0.0004 |
| 180 |
PRODUCT CONTAINER ISSUE |
3 |
0.0003 |
| 181 |
UPPER RESPIRATORY TRACT CONGESTION |
1 |
0.0003 |
| 182 |
TOOTH DISCOLOURATION |
1 |
0.0003 |
| 183 |
EYE INJURY |
1 |
0.0003 |
| 184 |
EYE PRURITUS |
11 |
0.0003 |
| 185 |
DIABETIC FOOT |
1 |
0.0003 |
| 186 |
MIDDLE INSOMNIA |
6 |
0.0003 |
| 187 |
EYELIDS PRURITUS |
1 |
0.0003 |
| 188 |
SWELLING OF EYELID |
2 |
0.0003 |
| 189 |
INFUSION SITE SWELLING |
2 |
0.0003 |
| 190 |
INFUSION SITE PRURITUS |
1 |
0.0003 |
| 191 |
RECALLED PRODUCT ADMINISTERED |
3 |
0.0003 |
| 192 |
EYE DISCHARGE |
3 |
0.0003 |
| 193 |
FACIAL PARESIS |
1 |
0.0003 |
| 194 |
PRODUCT CONTAMINATION |
1 |
0.0003 |
| 195 |
DEVICE KINK |
1 |
0.0003 |
| 196 |
EYE DISORDER |
9 |
0.0003 |
| 197 |
RETINOPATHY |
1 |
0.0003 |
| 198 |
EYE INFECTION |
3 |
0.0003 |
| 199 |
CATHETER SITE INFECTION |
1 |
0.0003 |
| 200 |
HERNIA |
5 |
0.0003 |
| 201 |
SPINAL PAIN |
3 |
0.0003 |
| 202 |
BLEPHARITIS |
1 |
0.0002 |
| 203 |
SENSORY DISTURBANCE |
4 |
0.0002 |
| 204 |
BLINDNESS |
10 |
0.0002 |
| 205 |
ENCEPHALOPATHY |
6 |
0.0002 |
| 206 |
MYDRIASIS |
3 |
0.0002 |
| 207 |
GINGIVAL SWELLING |
1 |
0.0002 |
| 208 |
IRON DEFICIENCY |
1 |
0.0002 |
| 209 |
ANAL INCONTINENCE |
2 |
0.0002 |
| 210 |
OROPHARYNGEAL DISCOMFORT |
2 |
0.0002 |
| 211 |
RETINAL DETACHMENT |
2 |
0.0002 |
| 212 |
EYE OPERATION |
1 |
0.0002 |
| 213 |
BLINDNESS UNILATERAL |
3 |
0.0002 |
| 214 |
VAGINAL INFECTION |
1 |
0.0002 |
| 215 |
FINGER DEFORMITY |
1 |
0.0002 |
| 216 |
ORGANISING PNEUMONIA |
1 |
0.0002 |
| 217 |
PROTEIN URINE PRESENT |
1 |
0.0002 |
| 218 |
HYPOTONIA |
2 |
0.0002 |
| 219 |
HEART RATE DECREASED |
7 |
0.0002 |
| 220 |
LACRIMATION INCREASED |
6 |
0.0002 |
| 221 |
INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION |
2 |
0.0002 |
| 222 |
POOR VENOUS ACCESS |
2 |
0.0002 |
| 223 |
THERAPY PARTIAL RESPONDER |
3 |
0.0002 |
| 224 |
PRODUCT SUBSTITUTION ISSUE |
11 |
0.0002 |
| 225 |
GASTROINTESTINAL MOTILITY DISORDER |
1 |
0.0002 |
| 226 |
FOOD POISONING |
1 |
0.0002 |
| 227 |
STRESS FRACTURE |
1 |
0.0002 |
| 228 |
INJECTION SITE INJURY |
1 |
0.0002 |
| 229 |
HEART RATE ABNORMAL |
1 |
0.0002 |
| 230 |
MACULAR OEDEMA |
1 |
0.0002 |
| 231 |
PRODUCT LEAKAGE |
1 |
0.0002 |
| 232 |
HEART RATE IRREGULAR |
4 |
0.0002 |
| 233 |
SCAB |
2 |
0.0002 |
| 234 |
RHEUMATOID FACTOR POSITIVE |
1 |
0.0002 |
| 235 |
UNINTENTIONAL MEDICAL DEVICE REMOVAL |
2 |
0.0002 |
| 236 |
VISUAL IMPAIRMENT |
21 |
0.0002 |
| 237 |
ENDOPHTHALMITIS |
1 |
0.0002 |
| 238 |
TOOTHACHE |
3 |
0.0002 |
| 239 |
PLATELET COUNT ABNORMAL |
1 |
0.0002 |
| 240 |
PNEUMONIA ASPIRATION |
4 |
0.0002 |
| 241 |
FRACTURE |
3 |
0.0002 |
| 242 |
FEELING JITTERY |
3 |
0.0002 |
| 243 |
BLOOD PRESSURE SYSTOLIC INCREASED |
3 |
0.0002 |
| 244 |
EXTRA DOSE ADMINISTERED |
6 |
0.0001 |
| 245 |
FREQUENT BOWEL MOVEMENTS |
4 |
0.0001 |
| 246 |
WRONG PRODUCT ADMINISTERED |
1 |
0.0001 |
| 247 |
PRODUCT LABEL ISSUE |
1 |
0.0001 |
| 248 |
PALLOR |
4 |
0.0001 |
| 249 |
JOINT EFFUSION |
1 |
0.0001 |
| 250 |
DELIRIUM |
5 |
0.0001 |
| 251 |
SEASONAL ALLERGY |
2 |
0.0001 |
| 252 |
DRY EYE |
7 |
0.0001 |
| 253 |
PRODUCT SUPPLY ISSUE |
1 |
0.0001 |
| 254 |
PRODUCT PRESCRIBING ISSUE |
3 |
0.0001 |
| 255 |
TRANSAMINASES INCREASED |
3 |
0.0001 |
| 256 |
PULMONARY OEDEMA |
6 |
0.0001 |
| 257 |
BRADYCARDIA |
7 |
0.0001 |
| 258 |
DEVICE FAILURE |
2 |
0.0001 |
| 259 |
VISION BLURRED |
18 |
0.0001 |
| 260 |
FOOD ALLERGY |
1 |
0.0001 |
| 261 |
PELVIC FRACTURE |
1 |
0.0001 |
| 262 |
HAEMORRHAGIC STROKE |
1 |
0.0001 |
| 263 |
BONE DENSITY DECREASED |
4 |
0.0001 |
| 264 |
MULTIPLE ALLERGIES |
1 |
0.0001 |
| 265 |
FURUNCLE |
1 |
0.0001 |
| 266 |
GINGIVAL PAIN |
1 |
0.0001 |
| 267 |
MOVEMENT DISORDER |
4 |
0.0001 |
| 268 |
STENT PLACEMENT |
1 |
0.0001 |
| 269 |
MYASTHENIA GRAVIS |
1 |
0.0001 |
| 270 |
ACUTE CORONARY SYNDROME |
1 |
0.0001 |
| 271 |
HEMIPLEGIA |
1 |
0.0001 |
| 272 |
INCORRECT ROUTE OF PRODUCT ADMINISTRATION |
2 |
0.0001 |
| 273 |
SKIN SWELLING |
1 |
0.0001 |
| 274 |
HAEMOLYTIC ANAEMIA |
1 |
0.0001 |
| 275 |
GOUT |
2 |
0.0001 |
| 276 |
UROSEPSIS |
1 |
0.0001 |
| 277 |
RHINORRHOEA |
7 |
0.0001 |
| 278 |
NECK PAIN |
6 |
0.0001 |
| 279 |
ERYTHEMA MULTIFORME |
1 |
0.0001 |
| 280 |
APPENDICITIS |
1 |
0.0001 |
| 281 |
OXYGEN SATURATION DECREASED |
6 |
0.0001 |
| 282 |
FLANK PAIN |
1 |
0.0001 |
| 283 |
DYSPNOEA EXERTIONAL |
4 |
0.0001 |
| 284 |
BLOOD SODIUM DECREASED |
2 |
0.0001 |
| 285 |
INFUSION RELATED REACTION |
7 |
0.0001 |
| 286 |
SPUTUM DISCOLOURED |
1 |
0.0001 |
| 287 |
PRODUCT PACKAGING ISSUE |
1 |
0.0001 |
| 288 |
SINUS BRADYCARDIA |
1 |
0.0001 |
| 289 |
VITREOUS FLOATERS |
1 |
0.0001 |
| 290 |
KNEE OPERATION |
1 |
0.0001 |
| 291 |
CATARACT |
6 |
0.0001 |
| 292 |
SALIVARY HYPERSECRETION |
1 |
0.0001 |
| 293 |
POOR QUALITY DEVICE USED |
1 |
0.0001 |
| 294 |
TOXIC SKIN ERUPTION |
1 |
0.0001 |
| 295 |
PRODUCT ADMINISTRATION ERROR |
2 |
0.0001 |
| 296 |
EYELID PTOSIS |
1 |
0.0001 |
| 297 |
INFLAMMATION |
5 |
0.0001 |
| 298 |
WEIGHT FLUCTUATION |
1 |
0.0001 |
| 299 |
SKIN CANCER |
2 |
0.0001 |
| 300 |
AMNESIA |
6 |
0.0001 |
| 301 |
DIABETES MELLITUS |
7 |
0.0001 |
| 302 |
BLOOD PRESSURE INCREASED |
14 |
0.0001 |
| 303 |
DENTAL CARIES |
1 |
0.0001 |
| 304 |
NERVE INJURY |
1 |
0.0001 |
| 305 |
THERAPY NON-RESPONDER |
4 |
0.0001 |
| 306 |
MYOCARDIAL ISCHAEMIA |
1 |
0.0001 |
| 307 |
DERMATITIS CONTACT |
1 |
0.0001 |
| 308 |
PERICARDIAL EFFUSION |
2 |
0.0001 |
| 309 |
MADAROSIS |
1 |
0.0001 |
| 310 |
EYELID OEDEMA |
1 |
0.0001 |
| 311 |
VASCULITIS |
1 |
0.0001 |
| 312 |
NASAL CONGESTION |
5 |
0.0001 |
| 313 |
COVID-19 PNEUMONIA |
1 |
0.0001 |
| 314 |
MACULAR DEGENERATION |
1 |
0.0001 |
| 315 |
LOCALISED INFECTION |
2 |
0.0001 |
| 316 |
BURSITIS |
1 |
0.0001 |
| 317 |
PRESYNCOPE |
2 |
0.0001 |
| 318 |
INJECTION SITE MASS |
3 |
0.0001 |
| 319 |
TENDON RUPTURE |
1 |
0.0001 |
| 320 |
HEART RATE INCREASED |
8 |
0.0001 |
| 321 |
CYST |
1 |
0.0001 |
| 322 |
MUSCLE ATROPHY |
1 |
0.0001 |
| 323 |
ROTATOR CUFF SYNDROME |
1 |
0.0001 |
| 324 |
ORAL CANDIDIASIS |
1 |
0.0001 |
| 325 |
ANKYLOSING SPONDYLITIS |
1 |
0.0001 |
| 326 |
TOOTH INFECTION |
1 |
0.0001 |
| 327 |
EYE HAEMORRHAGE |
1 |
0.0001 |
| 328 |
PRODUCT DOSE OMISSION ISSUE |
22 |
0.0001 |
| 329 |
HYPOTENSION |
15 |
0.0001 |
| 330 |
JOINT RANGE OF MOTION DECREASED |
1 |
0.0001 |
| 331 |
IMPAIRED GASTRIC EMPTYING |
1 |
0.0001 |
| 332 |
ANAPHYLACTIC REACTION |
4 |
0.0001 |
| 333 |
ORAL DISCOMFORT |
1 |
0.0001 |
| 334 |
POLLAKIURIA |
3 |
0.0001 |
| 335 |
CARPAL TUNNEL SYNDROME |
1 |
0.0001 |
| 336 |
PAIN IN JAW |
2 |
0.0001 |
| 337 |
INTENTIONAL DOSE OMISSION |
2 |
0.0001 |
| 338 |
RED BLOOD CELL COUNT DECREASED |
2 |
0.0001 |
| 339 |
PULMONARY ARTERIAL HYPERTENSION |
1 |
0.0001 |
| 340 |
ASCITES |
2 |
0.0001 |
| 341 |
URINARY INCONTINENCE |
2 |
0.0001 |
| 342 |
DRUG EFFECT LESS THAN EXPECTED |
1 |
0.0001 |
| 343 |
SKIN HAEMORRHAGE |
1 |
0.0001 |
| 344 |
COLON CANCER |
1 |
0.0001 |
| 345 |
IMMUNODEFICIENCY |
1 |
0.0001 |
| 346 |
RESPIRATORY DISORDER |
2 |
0.0001 |
| 347 |
INSURANCE ISSUE |
1 |
0.0001 |
| 348 |
DEVICE ADHESION ISSUE |
1 |
0.0001 |
| 349 |
THYROID DISORDER |
1 |
0.0001 |
| 350 |
MUSCULOSKELETAL CHEST PAIN |
1 |
0.0001 |
| 351 |
WRONG TECHNIQUE IN DEVICE USAGE PROCESS |
3 |
0.0001 |
| 352 |
BRAIN FOG |
1 |
0.0001 |
| 353 |
RESPIRATORY TRACT CONGESTION |
1 |
0.0001 |
| 354 |
ABSCESS |
1 |
0.0001 |
| 355 |
SWELLING FACE |
4 |
0.0001 |
| 356 |
HYPERTENSION |
13 |
0.0001 |
| 357 |
CHOLELITHIASIS |
2 |
0.0001 |
| 358 |
GENERAL PHYSICAL HEALTH DETERIORATION |
7 |
0.0001 |
| 359 |
VISUAL ACUITY REDUCED |
2 |
0.0001 |
| 360 |
THERAPY CESSATION |
3 |
0.0001 |
| 361 |
BALANCE DISORDER |
5 |
0.0001 |
| 362 |
DEVICE DEFECTIVE |
1 |
0.0001 |
| 363 |
NEOPLASM PROGRESSION |
2 |
0.0001 |
| 364 |
ABDOMINAL DISTENSION |
6 |
0.0001 |
| 365 |
OFF LABEL USE |
50 |
0.0001 |
| 366 |
INTENTIONAL PRODUCT USE ISSUE |
5 |
0.0001 |
| 367 |
EOSINOPHILIA |
1 |
0.0001 |
| 368 |
COVID-19 |
10 |
0.0001 |
| 369 |
HEAD DISCOMFORT |
1 |
0.0001 |
| 370 |
GASTROENTERITIS VIRAL |
1 |
0.0001 |
| 371 |
OSTEOMYELITIS |
1 |
0.0001 |
| 372 |
AGITATION |
4 |
0.0001 |
| 373 |
DYSURIA |
2 |
0.0001 |
| 374 |
EYE SWELLING |
2 |
0.0001 |
| 375 |
HALLUCINATION |
4 |
0.0001 |
| 376 |
FLATULENCE |
3 |
0.0001 |
| 377 |
DEHYDRATION |
7 |
0.0001 |
| 378 |
POST PROCEDURAL COMPLICATION |
1 |
0.0001 |
| 379 |
CONTUSION |
5 |
0.0001 |
| 380 |
ERUCTATION |
1 |
0.0001 |
| 381 |
PLASMA CELL MYELOMA |
2 |
0.0001 |
| 382 |
ORAL HERPES |
1 |
0.0001 |
| 383 |
SKIN FISSURES |
1 |
0.0001 |
| 384 |
FALL |
17 |
0.0001 |
| 385 |
HAEMATOCRIT DECREASED |
1 |
0.0001 |
| 386 |
UPPER LIMB FRACTURE |
1 |
0.0001 |
| 387 |
CYTOKINE RELEASE SYNDROME |
1 |
0.0000 |
| 388 |
DRY MOUTH |
4 |
0.0000 |
| 389 |
INJURY ASSOCIATED WITH DEVICE |
1 |
0.0000 |
| 390 |
BODY TEMPERATURE INCREASED |
1 |
0.0000 |
| 391 |
NASOPHARYNGITIS |
9 |
0.0000 |
| 392 |
RIB FRACTURE |
1 |
0.0000 |
| 393 |
TREATMENT FAILURE |
4 |
0.0000 |
| 394 |
DERMATITIS |
1 |
0.0000 |
| 395 |
PAIN IN EXTREMITY |
14 |
0.0000 |
| 396 |
RETCHING |
1 |
0.0000 |
| 397 |
POOR QUALITY SLEEP |
1 |
0.0000 |
| 398 |
DEEP VEIN THROMBOSIS |
3 |
0.0000 |
| 399 |
WHITE BLOOD CELL COUNT DECREASED |
5 |
0.0000 |
| 400 |
FAECES DISCOLOURED |
1 |
0.0000 |
| 401 |
DEVICE DISLOCATION |
2 |
0.0000 |
| 402 |
PRODUCT DOSE OMISSION |
3 |
0.0000 |
| 403 |
BLOOD CREATININE INCREASED |
3 |
0.0000 |
| 404 |
PRODUCT DISPENSING ERROR |
1 |
0.0000 |
| 405 |
ANGIOEDEMA |
2 |
0.0000 |
| 406 |
LIVER DISORDER |
2 |
0.0000 |
| 407 |
ORAL PAIN |
1 |
0.0000 |
| 408 |
PRODUCT AVAILABILITY ISSUE |
1 |
0.0000 |
| 409 |
SKIN IRRITATION |
2 |
0.0000 |
| 410 |
CONFUSIONAL STATE |
7 |
0.0000 |
| 411 |
COGNITIVE DISORDER |
2 |
0.0000 |
| 412 |
PALPITATIONS |
5 |
0.0000 |
| 413 |
CHILLS |
5 |
0.0000 |
| 414 |
PRODUCTIVE COUGH |
2 |
0.0000 |
| 415 |
SKIN BURNING SENSATION |
3 |
0.0000 |
| 416 |
BLOOD PRESSURE FLUCTUATION |
1 |
0.0000 |
| 417 |
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES |
2 |
0.0000 |
| 418 |
CEREBROVASCULAR ACCIDENT |
7 |
0.0000 |
| 419 |
NEURALGIA |
1 |
0.0000 |
| 420 |
OEDEMA PERIPHERAL |
5 |
0.0000 |
| 421 |
PNEUMONIA |
13 |
0.0000 |
| 422 |
GLYCOSYLATED HAEMOGLOBIN INCREASED |
1 |
0.0000 |
| 423 |
INCORRECT DOSE ADMINISTERED |
9 |
0.0000 |
| 424 |
WEIGHT DECREASED |
11 |
0.0000 |
| 425 |
COUGH |
11 |
0.0000 |
| 426 |
HYPOPHAGIA |
1 |
0.0000 |
| 427 |
MALIGNANT NEOPLASM PROGRESSION |
4 |
0.0000 |
| 428 |
SINUSITIS |
4 |
0.0000 |
| 429 |
PERIPHERAL SWELLING |
6 |
0.0000 |
| 430 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
7 |
0.0000 |
| 431 |
BACK PAIN |
9 |
0.0000 |
| 432 |
HAEMATOMA |
1 |
0.0000 |
| 433 |
EXPOSURE VIA SKIN CONTACT |
1 |
0.0000 |
| 434 |
INCORRECT DOSE ADMINISTERED BY DEVICE |
1 |
0.0000 |
| 435 |
JOINT STIFFNESS |
1 |
0.0000 |
| 436 |
PANCREATITIS |
2 |
0.0000 |
| 437 |
DEPRESSED MOOD |
2 |
0.0000 |
| 438 |
HYPERSENSITIVITY |
7 |
0.0000 |
| 439 |
EAR INFECTION |
1 |
0.0000 |
| 440 |
MEMORY IMPAIRMENT |
5 |
0.0000 |
| 441 |
CONDITION AGGRAVATED |
11 |
0.0000 |
| 442 |
PROCEDURAL PAIN |
1 |
0.0000 |
| 443 |
ARTHROPATHY |
2 |
0.0000 |
| 444 |
HYPONATRAEMIA |
2 |
0.0000 |
| 445 |
ASTHMA |
4 |
0.0000 |
| 446 |
PRODUCT DOSE OMISSION IN ERROR |
1 |
0.0000 |
| 447 |
INTERNATIONAL NORMALISED RATIO INCREASED |
1 |
0.0000 |
| 448 |
HERPES ZOSTER |
2 |
0.0000 |
| 449 |
LETHARGY |
2 |
0.0000 |
| 450 |
INFECTION |
5 |
0.0000 |
| 451 |
NEEDLE ISSUE |
1 |
0.0000 |
| 452 |
ACUTE MYOCARDIAL INFARCTION |
1 |
0.0000 |
| 453 |
WHEEZING |
2 |
0.0000 |
| 454 |
BLOOD POTASSIUM DECREASED |
1 |
0.0000 |
| 455 |
JOINT SWELLING |
4 |
0.0000 |
| 456 |
CONTRAINDICATED PRODUCT ADMINISTERED |
1 |
0.0000 |
| 457 |
VERTIGO |
2 |
0.0000 |
| 458 |
DISCOMFORT |
2 |
0.0000 |
| 459 |
PRODUCT USE IN UNAPPROVED INDICATION |
8 |
0.0000 |
| 460 |
SWELLING |
3 |
0.0000 |
| 461 |
PRODUCT USE ISSUE |
6 |
0.0000 |
| 462 |
HEADACHE |
20 |
0.0000 |
| 463 |
DRUG-INDUCED LIVER INJURY |
1 |
0.0000 |
| 464 |
FATIGUE |
24 |
0.0000 |
| 465 |
THERAPEUTIC RESPONSE SHORTENED |
1 |
0.0000 |
| 466 |
BLOOD PRESSURE DECREASED |
2 |
0.0000 |
| 467 |
EXPIRED PRODUCT ADMINISTERED |
1 |
0.0000 |
| 468 |
DRY SKIN |
4 |
0.0000 |
| 469 |
ANGER |
1 |
0.0000 |
| 470 |
PRODUCT QUALITY ISSUE |
4 |
0.0000 |
| 471 |
HAEMOGLOBIN DECREASED |
3 |
0.0000 |
| 472 |
ERYTHEMA |
6 |
0.0000 |
| 473 |
HYPOXIA |
1 |
0.0000 |
| 474 |
PLATELET COUNT DECREASED |
3 |
0.0000 |
| 475 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
2 |
0.0000 |
| 476 |
DIZZINESS |
14 |
0.0000 |
| 477 |
PAIN |
17 |
0.0000 |
| 478 |
C-REACTIVE PROTEIN INCREASED |
1 |
0.0000 |
| 479 |
HYPERGLYCAEMIA |
1 |
0.0000 |
| 480 |
MUSCLE SPASMS |
5 |
0.0000 |
| 481 |
EPISTAXIS |
2 |
0.0000 |
| 482 |
HOT FLUSH |
2 |
0.0000 |
| 483 |
BLOOD GLUCOSE INCREASED |
5 |
0.0000 |
| 484 |
MUSCULAR WEAKNESS |
3 |
0.0000 |
| 485 |
ACNE |
2 |
0.0000 |
| 486 |
INSOMNIA |
7 |
0.0000 |
| 487 |
WHITE BLOOD CELL COUNT INCREASED |
1 |
0.0000 |
| 488 |
ARTHRITIS |
2 |
0.0000 |
| 489 |
DYSKINESIA |
1 |
0.0000 |
| 490 |
NEUTROPHIL COUNT DECREASED |
1 |
0.0000 |
| 491 |
OSTEOPOROSIS |
1 |
0.0000 |
| 492 |
ABDOMINAL PAIN UPPER |
5 |
0.0000 |
| 493 |
OSTEOARTHRITIS |
1 |
0.0000 |
| 494 |
URINARY TRACT INFECTION |
4 |
0.0000 |
| 495 |
HYPOACUSIS |
1 |
0.0000 |
| 496 |
DEVICE LEAKAGE |
1 |
0.0000 |
| 497 |
PRODUCT STORAGE ERROR |
2 |
0.0000 |
| 498 |
MUSCULOSKELETAL STIFFNESS |
2 |
0.0000 |
| 499 |
MALAISE |
10 |
0.0000 |
| 500 |
NAUSEA |
18 |
0.0000 |
| 501 |
THROAT IRRITATION |
1 |
0.0000 |
| 502 |
DRUG INEFFECTIVE |
29 |
0.0000 |
| 503 |
UPPER RESPIRATORY TRACT INFECTION |
1 |
0.0000 |
| 504 |
RENAL DISORDER |
1 |
0.0000 |
| 505 |
CARDIAC DISORDER |
2 |
0.0000 |
| 506 |
ARRHYTHMIA |
1 |
0.0000 |
| 507 |
DYSPHAGIA |
2 |
0.0000 |
| 508 |
PULMONARY EMBOLISM |
2 |
0.0000 |
| 509 |
MIGRAINE |
2 |
0.0000 |
| 510 |
SYNCOPE |
2 |
0.0000 |
| 511 |
SOMNOLENCE |
4 |
0.0000 |
| 512 |
CELLULITIS |
1 |
0.0000 |
| 513 |
FLUID RETENTION |
1 |
0.0000 |
| 514 |
DYSPNOEA |
11 |
0.0000 |
| 515 |
ACCIDENTAL EXPOSURE TO PRODUCT |
2 |
0.0000 |
| 516 |
CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
1 |
0.0000 |
| 517 |
NERVOUSNESS |
1 |
0.0000 |
| 518 |
SPEECH DISORDER |
1 |
0.0000 |
| 519 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
1 |
0.0000 |
| 520 |
PRURITUS |
7 |
0.0000 |
| 521 |
WEIGHT INCREASED |
4 |
0.0000 |
| 522 |
MYALGIA |
3 |
0.0000 |
| 523 |
DEPRESSION |
4 |
0.0000 |
| 524 |
ANXIETY |
5 |
0.0000 |
| 525 |
DYSPHONIA |
1 |
0.0000 |
| 526 |
ARTHRALGIA |
7 |
0.0000 |
| 527 |
FEELING ABNORMAL |
4 |
0.0000 |
| 528 |
THERAPEUTIC RESPONSE DECREASED |
1 |
0.0000 |
| 529 |
PLEURAL EFFUSION |
1 |
0.0000 |
| 530 |
ALANINE AMINOTRANSFERASE INCREASED |
1 |
0.0000 |
| 531 |
CHEST PAIN |
3 |
0.0000 |
| 532 |
HYPERHIDROSIS |
2 |
0.0000 |
| 533 |
VOMITING |
7 |
0.0000 |
| 534 |
HEPATIC ENZYME INCREASED |
1 |
0.0000 |
| 535 |
BURNING SENSATION |
1 |
0.0000 |
| 536 |
THERAPY INTERRUPTED |
1 |
0.0000 |
| 537 |
DIARRHOEA |
9 |
0.0000 |
| 538 |
RASH |
6 |
0.0000 |
| 539 |
CONSTIPATION |
3 |
0.0000 |
| 540 |
UNDERDOSE |
1 |
0.0000 |
| 541 |
DYSGEUSIA |
1 |
0.0000 |
| 542 |
ASTHENIA |
5 |
0.0000 |
| 543 |
INJECTION SITE SWELLING |
1 |
0.0000 |
| 544 |
DECREASED APPETITE |
3 |
0.0000 |
| 545 |
INJECTION SITE HAEMORRHAGE |
1 |
0.0000 |
| 546 |
CARDIAC FAILURE CONGESTIVE |
1 |
0.0000 |
| 547 |
THROMBOSIS |
1 |
0.0000 |
| 548 |
GASTROOESOPHAGEAL REFLUX DISEASE |
1 |
0.0000 |
| 549 |
INFLUENZA LIKE ILLNESS |
1 |
0.0000 |
| 550 |
GASTROINTESTINAL HAEMORRHAGE |
1 |
0.0000 |
| 551 |
ABDOMINAL DISCOMFORT |
2 |
0.0000 |
| 552 |
SKIN EXFOLIATION |
1 |
0.0000 |
| 553 |
GASTROINTESTINAL DISORDER |
1 |
0.0000 |
| 554 |
DEVICE ISSUE |
1 |
0.0000 |
| 555 |
NO ADVERSE EVENT |
2 |
0.0000 |
| 556 |
OROPHARYNGEAL PAIN |
1 |
0.0000 |
| 557 |
NEUROPATHY PERIPHERAL |
1 |
0.0000 |
| 558 |
DRUG INTOLERANCE |
1 |
0.0000 |
| 559 |
ATRIAL FIBRILLATION |
1 |
0.0000 |
| 560 |
DYSPEPSIA |
1 |
0.0000 |
| 561 |
FLUSHING |
1 |
0.0000 |
| 562 |
CHEST DISCOMFORT |
1 |
0.0000 |
| 563 |
ILLNESS |
1 |
0.0000 |
| 564 |
DEATH |
8 |
0.0000 |
| 565 |
THROMBOCYTOPENIA |
1 |
0.0000 |
| 566 |
RHEUMATOID ARTHRITIS |
1 |
0.0000 |
| 567 |
PYREXIA |
3 |
0.0000 |
| 568 |
ABDOMINAL PAIN |
2 |
0.0000 |
| 569 |
LOSS OF CONSCIOUSNESS |
1 |
0.0000 |
| 570 |
RENAL FAILURE |
1 |
0.0000 |
| 571 |
HYPOAESTHESIA |
1 |
0.0000 |
| 572 |
PARAESTHESIA |
1 |
0.0000 |
| 573 |
URTICARIA |
1 |
0.0000 |
| 574 |
ANAEMIA |
1 |
0.0000 |
| 575 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
1 |
0.0000 |
| 576 |
OVERDOSE |
1 |
0.0000 |
| 577 |
INJECTION SITE PAIN |
1 |
0.0000 |